Lessons to be learned: A case study approach Chinese herbal nephropathy and urothelial malignancy

Journal of The Royal Society for the Promotion of Health

Volumn 122, Issue 4, 2002, Pages 266-267

  Mason, R G ^a   Donaldson, D ^b  

^a QUEEN MARGARET HOSPITAL   (United Kingdom)

^b Gatwick Park Hospital   (United Kingdom)

Author keywords

Aristolochia fangji; Chinese herbal nephropathy; Interstitial renal fibrosis; Urothelial malignancy

Indexed keywords

ACETAZOLAMIDE; ALKYLATING AGENT; AMFEPRAMONE; AMINOPHYLLINE; ANTIOBESITY AGENT; ARISTOLCHIA FANGJI EXTRACT; BELLADONNA ALKALOID; CARCINOGEN; CYCLOPHOSPHAMIDE; CYNARA SCOLYMUS EXTRACT; DNA; FENFLURAMINE; HERBACEOUS AGENT; MAGNOLIA OFFICIANALIS EXTRACT; PHENACETIN; STEPHANIA TETRANDRA EXTRACT; TAXANE DERIVATIVE; TAXOID; UNCLASSIFIED DRUG;

ARISTOLCHIA FANGJI; ARTHRITIS; ARTICHOKE; BELGIUM; CANCER RISK; CARCINOGENESIS; CHINESE HERB; CLINICAL TRIAL; DISEASE COURSE; DNA DAMAGE; DRUG APPROVAL; DRUG CONTROL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; ECZEMA; ENVIRONMENTAL EXPOSURE; HEALTH EDUCATION; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAGNOLIA OFFICINALIS; MEDICAL LITERATURE; MEDICINAL PLANT; NEPHROTOXICITY; NEPHROURETERECTOMY; OBESITY; PRESCRIPTION; REVIEW; SIDE EFFECT; SMOKING HABIT; STEPHANIA TETRANDRA; URINARY TRACT CANCER; URINARY TRACT DISEASE; UROTHELIUM; ADULT; CHEMICALLY INDUCED DISORDER; DRUG CONTAMINATION; FEMALE; INTERSTITIAL NEPHRITIS; MIDDLE AGED;

ADULT; BELGIUM; DISEASE PROGRESSION; DRUG CONTAMINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MIDDLE AGED; NEPHRITIS, INTERSTITIAL; OBESITY; UROLOGIC NEOPLASMS;

EID: 0036943309     PISSN: 14664240     EISSN: None     Source Type: Journal    
DOI: 10.1177/146642400212200415     Document Type: Review

References (14)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics 2000. CA Cancer J Clin 2000;50(1):7-33
2. Fraley EE. Cancer of the renal pelvis. In: Skinner DG, de Kernion JB, editors. Genito-Urinary Cancer. Philadelphia: WB Saunders, 1978
3. Messing EM. Urothelial tumours of the urinary tract. In: Walsch PC, Retik AB, Vaughan ED, Wein AL, editors. Campbells Urology. Eighth Edition. Saunders, 2002.
4. Petkovic SD. Epidemiology and treatment of renal pelvic and ureteral tumors. J Urol 1975;114(6):858-65
5. Vanherweghem JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91
6. Li YM. Chinese herbs and urothelial carcinoma. N Engl J Med 2000;343(17):1269
7. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342(23):1686-92
8. Lord GM, Tagore R, Cook T, Gower P, Pusey CD. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354:481-2
9. Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358:1515-6
10. Kessler DA. Cancer and herbs. N Engl J Med 2000;342(23):1742-3
11. Food and Drug Administration. www.cfsan.fda.gov/dms/ds-bot3.html (accessed December 2002)
12. Arlt VM, Stiborova M, Svhmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis 2002;17(4):265-77
13. Corns C, Metcalfe K. Risks associated with herbal slimming remedies. J Roy Soc Health 2002;122(4):213-9
14. Lis-Balchin M. Serious adverse effects between herbal remedies and conventional drugs taken simultaneously. J Roy Soc Health 2002;122(4):210